187 related articles for article (PubMed ID: 8625145)
1. Human cyclin D1 oncogene and esophageal squamous cell carcinoma.
Nakagawa H; Zukerberg L; Togawa K; Meltzer SJ; Nishihara T; Rustgi AK
Cancer; 1995 Aug; 76(4):541-9. PubMed ID: 8625145
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines.
Kurzrock R; Ku S; Talpaz M
Cancer; 1995 Jan; 75(2):584-90. PubMed ID: 7812927
[TBL] [Abstract][Full Text] [Related]
3. Differential polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma.
Gramlich TL; Fritsch CR; Maurer D; Eberle M; Gansler TS
Diagn Mol Pathol; 1994 Dec; 3(4):255-9. PubMed ID: 7866635
[TBL] [Abstract][Full Text] [Related]
4. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas.
Sheyn I; Noffsinger AE; Heffelfinger S; Davis B; Miller MA; Fenoglio-Preiser CM
Hum Pathol; 1997 Mar; 28(3):270-6. PubMed ID: 9042789
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the p16INK4, p15INK4B genes abnormality and the amplification of cyclin D1 gene in esophageal cancer].
Takamura H; Fushida S; Hashimoto T; Yagi M; Miyazaki I
Nihon Rinsho; 1996 Apr; 54(4):1043-8. PubMed ID: 8920671
[TBL] [Abstract][Full Text] [Related]
6. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
[TBL] [Abstract][Full Text] [Related]
7. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas.
Jares P; Fernández PL; Campo E; Nadal A; Bosch F; Aiza G; Nayach I; Traserra J; Cardesa A
Cancer Res; 1994 Sep; 54(17):4813-7. PubMed ID: 8062283
[TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas.
Tsuruta H; Sakamoto H; Onda M; Terada M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1529-36. PubMed ID: 8250909
[TBL] [Abstract][Full Text] [Related]
9. Amplification and expression of the human cyclin D gene in esophageal cancer.
Jiang W; Kahn SM; Tomita N; Zhang YJ; Lu SH; Weinstein IB
Cancer Res; 1992 May; 52(10):2980-3. PubMed ID: 1533816
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang W; Zhang YJ; Kahn SM; Hollstein MC; Santella RM; Lu SH; Harris CC; Montesano R; Weinstein IB
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):9026-30. PubMed ID: 8415648
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
[TBL] [Abstract][Full Text] [Related]
12. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma.
Gaffey MJ; Iezzoni JC; Meredith SD; Boyd JC; Stoler MH; Weiss LM; Zukerberg LR; Levine PA; Arnold A; Williams ME
Hum Pathol; 1995 Nov; 26(11):1221-6. PubMed ID: 7590696
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of cyclin D1 messenger RNA expression in head and neck squamous cell carcinomas.
Monden N; Nishizaki K; Fukushima K; Masuda Y; Tsukuda K; Shimizu K
Jpn J Cancer Res; 1997 Jul; 88(7):660-8. PubMed ID: 9310139
[TBL] [Abstract][Full Text] [Related]
15. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
Lebwohl DE; Muise-Helmericks R; Sepp-Lorenzino L; Serve S; Timaul M; Bol R; Borgen P; Rosen N
Oncogene; 1994 Jul; 9(7):1925-9. PubMed ID: 8208539
[TBL] [Abstract][Full Text] [Related]
16. [Loss of CDKN2 gene and amplification of cyclin D1 gene in human esophageal cancer].
Zheng J; Hou P; Zhou C
Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):408-11. PubMed ID: 9387288
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of cyclin D1 and cyclin E in N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis.
Wang QS; Sabourin CL; Wang H; Stoner GD
Carcinogenesis; 1996 Aug; 17(8):1583-8. PubMed ID: 8761413
[TBL] [Abstract][Full Text] [Related]
18. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
Naitoh H; Shibata J; Kawaguchi A; Kodama M; Hattori T
Am J Pathol; 1995 May; 146(5):1161-9. PubMed ID: 7747810
[TBL] [Abstract][Full Text] [Related]
19. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach.
Nakagawa H; Wang TC; Zukerberg L; Odze R; Togawa K; May GH; Wilson J; Rustgi AK
Oncogene; 1997 Mar; 14(10):1185-90. PubMed ID: 9121767
[TBL] [Abstract][Full Text] [Related]
20. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]